Long-Term Clinical Outcomes in Survivors of Coronavirus Outbreaks After Hospitalisation or Icu Admission: A Systematic Review and Meta-Analysis of Follow-Up Studies

Abstract

Objective:To determine the long-term clinical problems in adult survivors of coronavirus (CoV) infection [Coronavirus disease 2019 (COVID-19), Severe Acute Respiratory Syndrome (SARS) andMiddle East Respiratory Syndrome (MERS)] after hospitalisation or Intensive Care Unit (ICU) admission.Design: Systematic review and meta-analysis of the literature. Data sources: Ovid MEDLINE, EMBASE, CINAHL Plus and PsycINFO were searched using the strategy: (Coronavirus OR Coronavirus Infections OR COVID OR SARS virus OR Severe acute respiratory syndrome OR MERS OR Middle east respiratory syndrome) AND (Follow-up OR Follow-up studies OR Prevalence). Original studies reporting the clinical outcomes of adult survivors of coronavirus outbreaks two months after discharge or three months after admission were included. The quality of the studies was assessed using the Oxford Centre for Evidence-Based Medicine (OCEBM) 2009 Level of Evidence Tool. Meta-analysis was conducted to derive pooled estimates of prevalence and severity for different outcomes at time points up to 6 months follow-up and beyond 6 months follow-up. Results: The search yielded 1169 studies of which 28 were included in this review. There were 15 Level 1b, 8 Level 2b, 2 Level 3b and 3 Level 4 studies by OCEBM grading. Pooled analysis of studies revealed that complications commonly observed were impaired diffusing capacity for carbon monoxide (DLCO) [prevalence of 27.26%, 95% CI 14.87 to 44.57] and reduced exercise capacity [(6-minute walking distance (6MWD) mean 461m, 95% CI 449.66 to 472.71] at 6 months with limited improvement beyond 6 months. Coronavirus survivors had considerable prevalence of psychological disorders such as post-traumatic stress disorder (PTSD) [38.80%, CI 30.93 to 47.31], depression [33.20%, CI 19.80 to 50.02] and anxiety [30.04%, CI 10.44 to 61.26) beyond 6 months. These complications were accompanied by low Short Form 36 (SF-36) scores at 6 months and beyond indicating reduced quality of life which is present long-term. Conclusions: The long term clinical problems in survivors of CoV infections (SARS and MERS) after hospitalisation or Intensive Care Unit (ICU) admission include respiratory dysfunction, reduced exercise capacity, psychological problems such as PTSD, depression and anxiety, and reduced quality of life. Critical care, rehabilitation and mental health services should anticipate a high prevalence of these problems following COVID-19 and ensure their adequate and timely management with the aim of restoring premorbid quality of life. : medRxiv preprint Inclusion and Exclusion Criteria PopulationClinical studies involving adults with a confirmed diagnosis of coronavirus infection were included. ExposureStudies reporting patients with SARS, MERS or COVID-19 from current or previous outbreaks were included. Study DesignStudies had to follow-up patients for a minimum period of 2 months post-discharge or 3 months postadmission to be included in this review. Only primary research studies were included. Reviews, casereports and editoria...

Rehabilitation after COVID-19: an evidence-based approach

“…COVID-19 is predicted to challenge rehabilitation a second time, 4 with many more patients needing longer-term complex rehabilitation input. Unfortunately, even before this crisis, most patients needing rehabilitation did not receive it.…”

“…[1][2][3] An early systematic review of residual problems is equally incomplete, due to lack of evidence. 4 Medical services have responded effectively to the COVID-19 crisis, despite a similar lack of direct evidence. This article shows that rehabilitation can also provide evidence-based interventions based on existing evidence.…”

The Australian Institute of Sport framework for rebooting sport in a COVID-19 environment

“…Respiratory Pneumonia-Lung abnormalities have been seen on CT chest of symptomatic and asymptomatic cases 57,122,123 ARDS 124 Reduced aerobic capacity and increased respiratory distress Potential persisting restrictive lung patterns and reduced diffusion capacity These long-term respiratory complications been reported follow previous coronavirus epidemics (SARS, MERS) in non-athlete populations 119 Clinical assessment Graded exercise testing, VO2 max testing FBE, CRP, spirometry, lung ultrasound, chest X-ray, CT chest Respiratory review Cardiovascular Cardiomyopathy 47 Myocarditis 125 Pericardial effusion 126 Arrythmias 45,125 Autoimmune mimicry of vasculitis and thrombosis 49,127 A return to exercise with underlying cardiac complications could be contraindicated for some 120 Return to contact sports/trauma could be contraindicated for some Persisting inflammatory states…”

Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020)

“…reduced diffusion capacity, restrictive abnormalities, and small airways obstruction) has been identified within 2 weeks of discharge [19] and such abnormalities appear to be more common among patients whose acute COVID-19 was severe or who had high levels of inflammatory markers or abnormal coagulation, as reflected by D-dimer elevation [20]. Such lung function abnormalities are often accompanied by pulmonary fibrosis [20][21][22][23], which has been detected as early as 3 weeks after onset of symptoms regardless of whether the acute illness was mild, moderate or severe [24,25]. Emerging data also suggests that cardiovascular complications (i.e.…”